1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 03 AUGUST 2015

CNS Drug News 03 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - M&A Activity Ahead For Biogen
Industry Brief - Osmolex ER Awarded FDA ODD
Industry Trend Analysis - Data Keep Hopes Alive For Lilly's Solanezumab
Industry Brief - Isis Earns Milestone From Roche With ISIS-HTTRx Phase I/IIa Study Initiation
Industry Brief - MHRA Review Confirms Benefit/Risk Profile Of BI's Alteplase
Industry Brief - ANI/Sofgen Gain US Nimodipine Approval
Industry Brief - ICT Proceeding With ITI-007 Phase III Development For Bipolar Depression
Industry Brief - Neos Resubmits NDA For Amphetamine XR-ODT To Treat ADHD
Industry Brief - FDA Approves Deltoid Injection Site For Abilify Maintena
Industry Brief - CHMP Adopts Positive Opinion For Zalviso
Industry Brief - Elite Completes Enrolment And Dosing For ELI-200 Phase III Efficacy Trial
Industry Brief - PAION Completes Remimazolam Know-How/Technology Transfer From Ono
Industry Brief - Adapt Pharma Submits NDA For Narcan Nasal Spray
Industry Trend Analysis - 3D Printing Will Play Part In Future Of Personalised Medicine
Industry Brief - Eisai Submits Fycompa NDA In Japan For Partial Onset/PGTC Seizures
Industry Brief - Shire Reports Positive Top-Line Results From Vyvanse Maintenance Of Efficacy Study In BED
Industry Brief - Galena Launches Zuplenz In US
Industry Brief - Tesaro/Hengrui Announce Rolapitant Licence Agreement For China
Industry Brief - JCR/Eisai Conclude Feasibility Study Agreement On Application Of BBB Penetration Technology
Industry Trend Analysis - Allergan Strengthens Mental Health Pipeline But Transformational Deal Ahead
Industry Trend Analysis - Core Medicines To Drive Overall Growth For UCB

Table Of Contents

CNS Drug News 03 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.